Clinical trial
A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole…
NCT00460707 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00460707 |
|---|---|
| Title | A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults |
| Official title | A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant in Healthy Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Chemotherapy-Induced |
| Intervention type | Drug |
| Interventions | Casopitant 150 mg, Ketoconazole, Casopitant 150 mg matching placebo, Casopitant 50 mg, Casopitant 50 mg matching placebo |
| Enrollment | 85 |
| Start date | Apr 16, 2007 |
| Primary completion | Aug 27, 2007 |
| Completion | Aug 27, 2007 |
| First posted | Apr 16, 2007 |
| Last update posted | Aug 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: